Each year, approximately 70 million people suffer traumatic brain injury, which has a
significant physical, psychosocial and economic impact for patients and their families. It is …

Traumatic brain injury (TBI), a major public health problem accompanied with numerous
complications, usually leads to serve disability and huge financial burden. The adverse and …

The prediction of functional outcome after mild traumatic brain injury (mTBI) is challenging.
Conventional magnetic resonance imaging (MRI) does not do a good job of explaining the …

Traumatic brain injury (TBI) is a major worldwide neurological disorder with no
neuroprotective treatment available. Three-dimensional (3D) in vitro models of brain …

Background and Objectives Traumatic spinal cord injury (SCI) is highly heterogeneous, and
tools to better delineate pathophysiology and recovery are needed. Our objective was to …

The Australian Traumatic Brain Injury Initiative (AUS-TBI) aims to co-design a data resource
to predict outcomes for people with moderate-severe traumatic brain injury (TBI) across …

Background Patients with traumatic brain injury are a heterogeneous population, and the
most severely injured individuals are often treated in an intensive care unit (ICU). The …

Traumatic brain injury (TBI) and stress are prevalent worldwide and can both result in life-
altering health problems. While stress often occurs in the absence of TBI, TBI inherently …

Neurofilament light (NF-L) is an axonal protein that has shown promise as a traumatic brain
injury (TBI) biomarker. Serum NF-L shows a rather slow rise after injury, peaking after 1-2 …

Prognostication is challenging in patients with traumatic brain injury (TBI) in whom computed
tomography (CT) fails to fully explain a low level of consciousness. Serum biomarkers reflect …